NOTE 8 — Stock-Based Compensation
Stock-based compensation expense is as follows
(in thousands of dollars):
Schedule
of Stock Based Compensation Expense
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended | | |
Six Months Ended | |
| | |
June 30, | | |
June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Cost of revenues | |
$ | — | | |
$ | 13 | | |
$ | 13 | | |
$ | 15 | |
| Research and development | |
| — | | |
| 12 | | |
| 20 | | |
| 14 | |
| Sales and marketing | |
| — | | |
| 329 | | |
| 60 | | |
| 394 | |
| General and administrative | |
| 98 | | |
| 572 | | |
| 309 | | |
| 793 | |
| Stock-based
compensation expenses | |
$ | 98 | | |
$ | 926 | | |
$ | 402 | | |
$ | 1,216 | |
In 2026, continuing operations includes the stock-based
compensation of $309 for general and administrative. In 2025 the general and administrative stock-based compensation is included in discontinued
operations. For both years the other stock-based compensation is all included in discontinued operations.
Stock-based compensation in Cost of Revenues relates
to employees who focus on supply chain management.
Stock Options
Stock option activity for the six months ended
June 30, 2026, is set forth in the table below (price per share is in dollars):
Schedule of Stock Option Activity
| | |
Options | | |
Weighted
average
exercise
price per
share | | |
Weighted
average
remaining
contractual
life (in
years) | | |
Aggregate
Intrinsic
Value* | |
| Outstanding at January 1, 2026 | |
| 34,883 | | |
$ | 110.67 | | |
| | | |
| | |
| Granted | |
| — | | |
| — | | |
| | | |
| | |
| Exercised | |
| — | | |
| — | | |
| | | |
| | |
| Forfeited and Expired | |
| (32,162 | ) | |
| 110.52 | | |
| | | |
| | |
| Outstanding at June 30, 2026 | |
| 2,721 | | |
$ | 112.53 | | |
| 7.38 | | |
$ | — | |
| Vested and Expected to Vest at June 30, 2026 | |
| 2,721 | | |
$ | 112.53 | | |
| 7.38 | | |
$ | — | |
| Exercisable at June 30, 2026 | |
| 2,374 | | |
$ | 112.79 | | |
| 7.32 | | |
$ | — | |
| * | The intrinsic value is calculated
as the difference between the exercise price and the fair value of the common stock on the balance sheet date. |
As of June 30, 2026, there was approximately $25
of unamortized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average
period of 0.77 years.
Restricted Stock Units
Restricted Stock Unit (“RSU”) activity
for the six months ended June 30, 2026, is set forth in the table below:
Schedule
of Outstanding Restricted Stock Units
| | |
RSUs | |
| Outstanding at January 1, 2026 | |
| — | |
| Granted | |
| 85,000 | |
| Released | |
| — | |
| Forfeited | |
| — | |
| Outstanding at June 30, 2026 | |
| 85,000 | |
Warrants activity, as adjusted for the Reverse
Stock Split, for the three months ended June 30, 2026, is as follows:
Schedule
of Warrant Activity
| | |
Number of warrants | | |
Weighted
average
exercise
price per
share | |
| Outstanding at January 1, 2026 | |
| 62,979 | | |
$ | 13.75 | |
| Granted | |
| — | | |
| — | |
| Forfeited | |
| — | | |
| — | |
| Expired | |
| — | | |
| — | |
| Outstanding at June 30, 2026 | |
| 62,979 | | |
$ | 13.75 | |
| Exercisable at June 30, 2026 | |
| 62,979 | | |
$ | 13.75 | |
|